Author

Drosia Kleta

Observed names: D Kleta, D. Kleta, Kleta, D

Institutions: Ippokrateio General Hospital of Thessaloniki, Hippocration General Hospital

Observed institutions: Aristotle University of Thessaloniki, Ippokrateio General Hospital of Thessaloniki, Hippocration General Hospital

OpenAlex ID: A5017755331

Targeting vascular risk in patients with metabolic syndrome but without diabetes

2005 · Vasilios G. Athyros, Dimitri P. Mikhailidis, et al. · Metabolism · 66

Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease

2013 · Emmanuil S. Hatzipantelis, Zoe Dorothea Pana, et al. · International Journal of Hematology · 55

Thrombomodulin and von Willebrand Factor: Relation to Endothelial Dysfunction and Disease Outcome in Children with Acute Lymphoblastic Leukemia

2010 · Emmanouel S. Hatzipantelis, Miranda Athanassiou-Metaxa, et al. · Acta Haematologica · 31

Prevalence of thrombophilic mutations in patients with unprovoked thromboembolic disease. A comparative analysis regarding arterial and venous disease.

2012 · E Mandala, C Lafaras, et al. · Europe PMC (PubMed Central) · 6

2010 · Vasiliki Kaloutsi, Georgia Karayannopoulou, et al. · Acta Haematologica · 4

The effect of L-thyroxine substitution on lipid profile, glucose homeostasis and coagulation in patients with subclinical hypothyroidism

2012 · Zoe Efstathiadou, Panagiotis Anagnostis, et al. · 15th International & 14th European Congress of Endocrinology

P.69 Venous thromboembolism in women; One year experience from a thrombophilia clinic

2011 · E. Lefkou, S. Vakalopoulou, et al. · Thrombosis Research

T03-P-002 Targeting cardiovascular risk plunge in metabolic syndrome: The targets study

2005 · V. Athyros, D. Mikhailidis, et al. · Atherosclerosis Supplements

Works count: 9

Citation count: 162

H-index: 4

I10-index: 3